• 1
    Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 204953.
  • 2
    Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995; 109: 15416.
  • 3
    Madri JA. Inflammation and healing. In: Kissane, JM, ed. Anderson's Pathology, Vol. 1, 9th edn. St Louis, MO: Mosby, 1990: 67110.
  • 4
    Spechler SJ. Barrett's esophagus. Semin Oncol 1994; 21: 4317.
  • 5
    Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995; 19 (Suppl. 1): S3743.
  • 6
    Genta RM, Huberman RM, Graham DY. The gastric cardia in Helicobacter pylori infection. Hum Pathol 1994; 25: 9159.
  • 7
    Hackelsberger A, Gunther T, Shultze V, et al. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut 1998; 43: 1721.
  • 8
    Chen YY, Antonioli DA, Spechler SJ, Zeroogian JM, Goyal RK, Wang HH. Gastroesophageal reflux disease vs. Helicobacter pylori infection as the cause of gastric carditis. Mod Pathol 1998; 11: 9506.
  • 9
    Goldblum JR, Vicari JJ, Falk GW, et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology 1998; 114: 6339.
  • 10
    Morales TG, Sampliner RE, Bhattacharyya A. Intestinal metaplasia of the gastric cardia. Am J Gastroenterol 1997; 92: 4148.
  • 11
    Pieramico O, Zanetti MV. Relationship between intestinal metaplasia of the gastro-oesophageal junction, H. pylori infection and gastro-oesophageal reflux disease: a prospective study. Dig Liver Dis 2000; 32: 56772.
  • 12
    Morini S, Zullo A, Hassan C, et al. Gastric cardia inflammation: role of Helicobacter pylori infection and symptoms of gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 233740.
    Direct Link:
  • 13
    McNamara D, Buckley M, Crotty P, et al. Carditis: all Helicobacter pylori or is there a role for gastro-oesophageal reflux? Scand J Gastroenterol 2002; 37: 7727.
  • 14
    Csendes A, Smok G, Burdiles P, et al. ‘Carditis’: an objective histological marker for pathologic gastroesophageal reflux disease. Dis Esophagus 1998; 11: 1015.
  • 15
    Oberg S, Peter JH, DeMeester TR, et al. Inflammation and specialized intestinal metaplasia of cardia mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997; 226: 52232.
  • 16
    Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994; 344: 15336.
  • 17
    Carton E, Caldwell MTP, McDonald G, et al. Specialized intestinal metaplasia in patients with gastro-oesophageal reflux disease. Br J Surg 2000; 87: 11621.
  • 18
    Oksanen A, Sipponen P, Karttunen R, et al. Inflammation and intestinal metaplasia at the squamocolumnar junction in young patients with or without Helicobacter pylori infection. Gut 2003; 52: 1948.
  • 19
    Chandrasoma PT, Lokuhetty DM, Demeester TR, et al. Definition of histopathologic changes in gastroesophageal reflux disease. Am J Gastroenterol 2000; 24: 34451.
  • 20
    Dent J. Gastro-oesophageal reflux disease. Digestion 1998; 59: 43345.
  • 21
    Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996; 110: 198296.
  • 22
    Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 11: 8592.
  • 23
    Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The update Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 116181.
  • 24
    Mela GS, Savarino V, Vigneri S. Optimizing the information obtained from continuous 24-hour gastric pH-monitoring. Am J Gastroenterol 1992; 87: 9616.
  • 25
    Johnson LF, DeMeester TR. Twenty-four hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974; 62: 32532.
  • 26
    Zentilin P, Conio M, Mele MR, et al. Comparison of the main oesophageal pathophysiological characteristics between short- and long-term Barrett's oesophagus. Aliment Pharmacol Ther 2002; 16: 8938.
  • 27
    Goldblum JR. Inflammation and intestinal metaplasia of the gastric cardia: Helicobacter pylori, gastroesophageal reflux disease, or both. Dig Dis 2000; 18: 149.
  • 28
    Kilgore SP, Ormsby AH, Gramlich TL, et al. The gastric cardia: fact or fiction? Am J Gastroenterol 2000; 95: 9214.
    Direct Link:
  • 29
    Spechler SJ. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology 1999; 117: 21828.
  • 30
    Hayward J. The lower end of the esophagus. Thorax 1961; 16: 3641.
  • 31
    Lembo T, Ippoliti AF, Ramers C, et al. Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study. Gut 1999; 45: 4848.
  • 32
    Wolf C, Seldenrijk CA, Timmer R, Breumelof R, Smout AJPM. Does carditis have two different etiologies? Dig Dis Sci 2001; 46: 242432.
  • 33
    Miyagawa Y. The exact distribution of the gastric glands in man and in certain animals. J Anat 1972; 55: 5667.
  • 34
    Ormsby AH, Goldblum JR, Kilgore SP, et al. The frequency and nature of cardia mucosa and intestinal metaplasia (IM) of the esophagogastric junction (EGJ): a population-based study of 223 consecutive autopsies. Gastroenterology 1999; 116: A273 (abstract).
  • 35
    De Hertogh G, Van Eyken P, Ectors N, et al. On the existence and location of cardia mucosa: an autopsy study in embryos, fetuses and infants. Gut 2003; 52: 7916.
  • 36
    Hackelsberger A, Gunther T, Schultze V, et al. Prevalence and pattern of Helicobacter pylori gastritis in the gastric cardia. Am J Gastroenterol 1997; 92: 22204.
  • 37
    Katzka DA, Gideon RM, Castell DO. Normal patterns of acid exposure at the gastric cardia: a functional midpoint between the esophagus and stomach. Am J Gastroenterol 1998; 93: 123642.
    Direct Link:
  • 38
    Dixon MF, Mapstone NP, Neville PM, et al. Bile reflux gastritis and intestinal metaplasia at the cardia. Gut 2002; 51: 3515.
  • 39
    Villani L, Trespi E, Fiocca R, et al. Analysis of gastroduodenitis and oesophagitis in relation to dyspeptic/reflux symptoms. Digestion 1998; 59: 91101.
  • 40
    Lanzafame S, Torrisi A, Favara C, Russo V, Emmanuele C. Correlation between intestinal metaplasia of the gastric cardia and gastroesophageal reflux disease. Hepatogastroenterology 2001; 48: 100710.
  • 41
    Csendes A, Smok G, Quiroz J, et al. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia. Am J Gastroenterol 2002; 97: 55460.
    Direct Link:
  • 42
    Voutilainen M, Farkkila M, Mecklin JP, Juhola M, Sipponen P. Complete and incomplete intestinal metaplasia at the esophagogastric junction. Prevalence and associations with endoscopic erosive esophagitis and gastritis. Gut 1999; 45: 6448.
  • 43
    Goldblum JR, Richter JE, Vaezi M, et al. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardia mucosa. Am J Gastroenterol 2002; 97: 30211.
    Direct Link:
  • 44
    Bowrey DJ, Clark GN, Williams G. Patterns of gastritis in patients with gastroesophageal reflux disease. Gut 1999; 45: 798803.
  • 45
    O'Connor HJ. Review article: Helicobacter pylori and gastroesophageal reflux disease. Clinical implications and management. Aliment Pharmacol Ther 1999; 13: 11727.
  • 46
    Der R, Tsao-Wei DD, Demeester T, et al. Carditis. A manifestation of gastroesophageal reflux disease. Am J Surg Pathol 2001; 25: 24552.
  • 47
    Csendes A, Smok G, Sagastume H, Rojas J. Biopsy and endoscopic prospective study of the prevalence of intestinal metaplasia in the gastroesophageal junction in controls and in patients with gastroesophageal reflux. Rev Med Chil 1998; 126: 15561.
  • 48
    O'Connor HJ. Gastro-oesophageal reflux disease, Helicobacter pylori and gastric cardia. A tale of two pathologies? Dig Liver Dis 2000; 32: 5736.
  • 49
    Sharma P, Topalovski M, Mayo MS, et al. Helicobacter pylori eradication dramatically improves inflammation in the gastric cardia. Am J Gastroenterol 2000; 95: 310711.
    Direct Link: